MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 29 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,251,000 | -61.5% | 3,795,225 | -45.1% | 0.29% | -56.0% |
| Q4 2021 | $11,052,000 | -33.9% | 6,907,189 | 0.0% | 0.67% | -11.3% |
| Q3 2021 | $16,715,000 | +24.9% | 6,907,189 | +63.6% | 0.75% | +29.7% |
| Q2 2021 | $13,380,000 | -5.9% | 4,220,938 | 0.0% | 0.58% | +15.8% |
| Q1 2021 | $14,225,000 | -5.9% | 4,220,938 | 0.0% | 0.50% | -25.8% |
| Q4 2020 | $15,111,000 | -7.3% | 4,220,938 | -32.1% | 0.67% | -28.5% |
| Q3 2020 | $16,299,000 | +584.5% | 6,220,938 | +699.6% | 0.94% | +450.9% |
| Q2 2020 | $2,381,000 | – | 778,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |